EGI
FATE icon

EAM Global Investors’s Fate Therapeutics FATE Stock Holding History

EAM Global Investors’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-49,796
Closed -$773K – 123
2019
Q3 		$773K Sell
49,796
-41,536
-45% -$796K 0.38% 109
2019
Q2 		$1.85M Hold
91,332
– – 0.79% 41
2019
Q1 		$1.6M Sell
91,332
-11,793
-11% -$186K 0.71% 62
2018
Q4 		$1.32M Hold
103,125
– – 0.72% 70
2018
Q3 		$1.68M Buy
103,125
+25,236
+32% +$298K 0.68% 48
2018
Q2 		$883K Hold
77,889
– – 0.43% 136
2018
Q1 		$760K Buy
+77,889
New +$746K 0.39% 127

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GH
Grosvenor Holdings Chicago, Illinois $512M AUM 19.57% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return